External-Beam Radiotherapy for Localized Prostate Cancer
- 12 October 2006
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (15), 1583-1591
- https://doi.org/10.1056/nejmct055263
Abstract
External-beam radiotherapy is recommended for a 69-year-old man with localized prostate cancer. This therapy has evolved rapidly owing to the development of sophisticated techniques for focusing the radiation beam precisely on its target. Important adverse effects include radiation proctitis, cystitis, urethritis, and erectile dysfunction.This publication has 45 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Pretreatment PSA Velocity and Risk of Death From Prostate Cancer Following External Beam Radiation TherapyPublished by American Medical Association (AMA) ,2005
- Molecular pathology of prostate cancerJournal of Clinical Pathology, 2005
- External Beam Radiotherapy as Curative Treatment of Prostate CancerMayo Clinic Proceedings, 2005
- Human prostate cancer risk factorsCancer, 2004
- Molecular Pathways to Prostate CancerJournal of Urology, 2003
- Prostate CancerNew England Journal of Medicine, 2003
- AJCC Cancer Staging ManualPublished by Springer Science and Business Media LLC ,2002
- Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millenniumUrology, 2001
- Pretreatment Nomogram for Predicting the Outcome of Three-Dimensional Conformal Radiotherapy in Prostate CancerJournal of Clinical Oncology, 2000